KORU Medical Systems, Inc. $KRMD Shares Purchased by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. increased its stake in KORU Medical Systems, Inc. by 220.5% in the first quarter, owning approximately 0.47% of the company worth $546,000.
• KORU Medical Systems reported a quarterly EPS of $0.01, exceeding the consensus estimate of ($0.03) and generating $10.20 million in revenue, higher than the expected $9.46 million.
• Despite a 1-year high of $5.05, KORU Medical's stock is currently trading down 0.2% at $4.22 with a consensus price target of $4.63 from analysts.

Russell Investments Group Ltd. increased its position in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD - Free Report) by 220.5% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 214,908 shares of the company's stock after purchasing an additional 147,857 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.47% of KORU Medical Systems worth $546,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. increased its position in shares of KORU Medical Systems by 11.8% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 66,917 shares of the company's stock worth $170,000 after purchasing an additional 7,046 shares in the last quarter. Northern Trust Corp increased its position in shares of KORU Medical Systems by 11.2% during the fourth quarter. Northern Trust Corp now owns 79,175 shares of the company's stock worth $305,000 after purchasing an additional 7,967 shares in the last quarter. HighTower Advisors LLC increased its position in shares of KORU Medical Systems by 18.4% during the first quarter. HighTower Advisors LLC now owns 51,400 shares of the company's stock worth $131,000 after purchasing an additional 8,000 shares in the last quarter. Millennium Management LLC increased its position in shares of KORU Medical Systems by 4.5% during the fourth quarter. Millennium Management LLC now owns 283,710 shares of the company's stock worth $1,092,000 after purchasing an additional 12,187 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of KORU Medical Systems by 2,770.7% during the fourth quarter. JPMorgan Chase & Co. now owns 17,712 shares of the company's stock worth $68,000 after purchasing an additional 17,095 shares in the last quarter. 58.60% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Piper Sandler dropped their price target on KORU Medical Systems from $4.50 to $3.50 and set a "neutral" rating for the company in a research report on Thursday, May 8th. One analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $4.63.

KORU Medical Systems Trading Up 1.4%

Shares of NASDAQ KRMD traded up $0.06 during mid-day trading on Thursday, reaching $4.10. 27,266 shares of the company's stock were exchanged, compared to its average volume of 194,376. The firm has a market capitalization of $189.33 million, a price-to-earnings ratio of -45.50 and a beta of 0.57. The company has a debt-to-equity ratio of 0.01, a quick ratio of 2.25 and a current ratio of 2.91. KORU Medical Systems, Inc. has a 52-week low of $1.86 and a 52-week high of $5.05. The company's 50-day moving average is $3.75 and its 200-day moving average is $3.21.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.04. The business had revenue of $10.20 million during the quarter, compared to analysts' expectations of $9.46 million. KORU Medical Systems had a negative return on equity of 26.77% and a negative net margin of 12.24%. Analysts expect that KORU Medical Systems, Inc. will post -0.13 EPS for the current fiscal year.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.